Transforming Healthcare with Engineering Biology: From Lab to Patient

Explore how engineering biology is transforming healthcare through RNA vaccines, therapeutics and precision medicine.

Transforming Healthcare with Engineering Biology: From Lab to Patient.
Transforming Healthcare with Engineering Biology: From Lab to Patient.

Our podcast People in Innovation continues its Engineering Biology series, and this week we're exploring how it's transforming healthcare with cutting-edge technologies, like RNA vaccines and therapeutics.

You can also watch it on YouTube

Allow YouTube content?

This page contains content provided by YouTube. We ask for your permission before anything is loaded, as they may be using cookies and other technologies for tracking and advertising. You may want to read their cookie policy and privacy policy before accepting. To view this content, choose ‘Accept and continue’.

In this episode, host Steve Bagshaw, Chair of High Value Manufacturing Catapult, is joined by Antony Hitchcock at AGH Bioconsulting, and Philip Probert, Director of Biologics & RNA Centre of Excellence at CPI, to talk us through the journey from lab to patient. They also highlight how engineering biology is shifting healthcare towards precision, programmable therapies, accelerating vaccine development and unlocking new treatments for previously unmet needs.

Despite major advancements in the field, challenges remain in scaling and manufacturing these therapies reliably and affordably, highlighting the need for facilities like CPI’s RNA Centre of Excellence and the UK RNA Biofoundry to bridge the gap and realise the full potential of this technology.

Join this discussion on the future of healthcare innovation, the challenges ahead, and the opportunity for the UK to lead.

Share